I expected this bad news in private. I did not want to

New Post Public Reply Private Reply Replies (1) Message Board
Millonario jhinvestor51 #1282
416
I expected this bad news in private. I did not want to discuss it openly so as not to cause panic. But this is what happens when a struggling company is bought by another with strengths.

What we do not know is what our destiny will be.

One part tells me that the SPLIT REVERSE was necessary in order to convert the GTRQ shares to that of the other company so that we enter as we deserve and as the shareholders of the other company that we enter.

But it seems that the buying company has another nature has nothing to do with the nature of Go Traq. So another possible scenario is to keep GTRQ apart. If this is the case I do not understand why the Reverse Split. But time will tell us.

If GTRQ is preserved then other questions to come.

Will they make a change in the A/S and increase that number?

If they do then we will be completely massacred.

If they do not increase the A / S?

(1) I read that there was an "Ask" for $ 5.00 and this may be a sign. Obviously, the "Bid" did not respond to that figure and some transactions were made as they say for $ 0.25

(2) Making a REVERSE SPLIT at 100: 1 causes the A/S to fall from 300,000,000 shares to 3,000,000 shares. And the O/S believed to be in 100,000,000 shares (approx) would fall to 1,000,000 shares

(3) If they hold 3 million shares A/S and 1 Million shares O/S then the way for GTRQ to apply to NASDAQ would be seen as part of the interest if we take that $ 5 BID as an aspirational, symbolic price.

(4) Another point to keep in mind is that years ago Gregg drew the first budget year for sales and marked it at $ 100,000,000,oo for the first year.

(5) In line with what I'm exposing, and if the A / S remains intact after the 100: 1 Reverse Split the upgrade to Nasdaq for GTRQ could be very fast. Depending on the status of the "Certification" could be this same year at the end, or very early in the year 2018.

(6) One of NASDAQ's requirements for a company to enter its market is that its share maintains a stable price above $ 4 for 30 consecutive days. Then the symbolic price "ASK" to $ 5 would be completely a goal to reach.

(7) If this I think is true. And the new management works well the next steps. Most likely there is a very fast rise in positions pointing to those prices. It will perhaps be a cost for the company to keep the price above $ 4 for those 30 consecutive days as it is one of the requirements NASDAQ

(8) According to a formula created by me, very empirical. If Gregg's sales budget to $ 100 million was given to only 1/4 of that amount, in half the time. In less than a year the new company would fly much higher the value of the share. Nieveles that leave completely of my formula, perhaps because I have calculated it from companies NASDAQ of medium and high level.

(9) If the new company works this well, then that $ 5 symbolic "ASK" is not a "Roof" but a "Floor". Then there would be no cost for the new company to hold the price above $ 4 for 30 days because it would be so explosive price growth, as every month the new sales report

(10) If the company decides to keep GTRQ and does not change its A / S after 100: 1 the numbers can be as exaggerated as crazy as to the price increase as the speed of it. My personal experience has never been good but quite the contrary. So my best average would be to aspire to recover my $ 6,000 bought 40,000 shares that would reduce me 100: 1 to 400 shares. In order to recover my investment, I would have each share to be located at $ 15 and even if it seems insane, that and more is perfectly possible and soon if (a) The A / S is not changed and (b) Gregg's invention is still so valid and Well, new managment is able to raise in sales at least half of what he expected.

In my opinion, and as I am so accustomed to being so abused rather than benefited. The only echo of just recovering my investment considering that represents each share reaches $ 15. To aspire to just that seems to me too much. Although my formula and everything I tell you says you could reach that price and get over it

Another of the data we have to remember about the invention and the project, is that we have 2 references in the background make clear that if this project and invention is handled well. Estimates can be immensely multiplied up on demand. The two data are on the one hand the advance sale made by iTRAQ from that page where the advanced sales performed far exceeded the expectations of ROMAN. The other antecedent was the TV program of new inventions, their test and opinions of potential buyers. The response was extremely positive.

To write this, I have supported Google Translate and what I fluently dominate in English so that I can give you something that I hope can be easy to read and understand. In case of difficulties, I hope you will excuse me.

Traack Technologies Inc. (TRAA) Stock Research Links

TRAA Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 0

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 2

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 0

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 3

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading

Top 5 Most Recently Viewed Articles

Conformal Coatings Market Set for Significant Growth by 2032

Updated Category News Views 233

The conformal coatings market surged ahead with projections showing it could reach USD 1.7 billion by 2032. This translates into a compound annual growth rate (CAGR) of 5.7% from 2024 to 2032, driven primarily by advancements in electronic protection technologies. Traders had better keep their eyes peeled—this ain't just a bump; it's a substantial shift. What’s...

Continue Reading
Japanese Mobile Battery Industry Forecasts Significant Growth

Updated Category News Views 122

Japan Mobile Battery Market Overview The mobile battery market in Japan is witnessing significant growth, with a valuation of JPY 207.96 billion in 2024 and projected to escalate to JPY 358.97 billion by 2033, marking a compound annual growth rate (CAGR) of 6.48% from 2025 to 2033. This growth trajectory highlights not only increasing consumer demands but also rapidly...

Continue Reading
Givastomig: A Promising Player in Gastric Cancer Therapy

Updated Category News Views 74

Givastomig's Advances in Gastric Cancer Research I-Mab (NASDAQ: IMAB), a biotech firm focused on developing cancer immunotherapies, recently presented exciting results from its Phase 1 clinical trial involving givastomig. This innovative bispecific antibody immunostimulant was unveiled at a prominent medical conference, demonstrating its effectiveness in treating advanced...

Continue Reading
Rani Therapeutics Partners with Chugai for Drug Delivery Breakthrough

Updated Category News Views 245

Rani Therapeutics Engages with Chugai Pharmaceutical Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) recently announced a significant collaborative effort with Chugai Pharmaceutical Co., Ltd., resulting in an enthusiastic response from investors. This collaboration aims to utilize Rani's innovative RaniPill oral drug delivery system alongside Chugai's experimental...

Continue Reading
Revizto's Brand Revamp: A Bold Step Towards Future Growth

Updated Category News Views 142

Revizto Introduces a Fresh Brand Identity As project complexities continue to rise in the construction industry, Revizto is making important modifications to its public image. The renowned collaboration platform, specifically designed for the Architecture, Engineering, Construction, and Operations (AECO) sectors, recently unveiled its refreshed brand identity,...

Continue Reading